Untargeted Metabolite Profiling of Cerebrospinal Fluid Uncovers Biomarkers for Severity of Late Infantile Neuronal Ceroid Lipofuscinosis (CLN2, Batten Disease)-Reference-Cited by-同舟云学术

Untargeted Metabolite Profiling of Cerebrospinal Fluid Uncovers Biomarkers for Severity of Late Infantile Neuronal Ceroid Lipofuscinosis (CLN2, Batten Disease)

Published:2018-10-15 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Sindelar Miriam,Dyke Jonathan P.^ORCID,Deeb Ruba S.,Sondhi Dolan,Kaminsky Stephen M.,Kosofsky Barry E.,Ballon Douglas J.,Crystal Ronald G.,Gross Steven S.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-33449-0.pdf

Reference35 articles.

1. Jalanko, A. & Braulke, T. Neuronal ceroid lipofuscinoses. Biochim Biophys Acta 1793, 697–709, https://doi.org/10.1016/j.bbamcr.2008.11.004 (2009).

2. Sleat, D. E. et al. Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. Science 277, 1802–1805 (1997).

3. Lin, L., Sohar, I., Lackland, H. & Lobel, P. The human CLN2 protein/tripeptidyl-peptidase I is a serine protease that autoactivates at acidic pH. J Biol Chem 276, 2249–2255, https://doi.org/10.1074/jbc.M008562200 (2001).

4. Rawlings, N. D. & Barrett, A. J. Tripeptidyl-peptidase I is apparently the CLN2 protein absent in classical late-infantile neuronal ceroid lipofuscinosis. Biochim Biophys Acta 1429, 496–500 (1999).

5. Ezaki, J., Takeda-Ezaki, M., Oda, K. & Kominami, E. Characterization of endopeptidase activity of tripeptidyl peptidase-I/CLN2 protein which is deficient in classical late infantile neuronal ceroid lipofuscinosis. Biochem Biophys Res Commun 268, 904–908, https://doi.org/10.1006/bbrc.2000.2207 (2000).

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CLN3 deficiency leads to neurological and metabolic perturbations during early development;Life Science Alliance;2024-01-09

2. An evaluation of untargeted metabolomics methods to characterize inborn errors of metabolism;Molecular Genetics and Metabolism;2024-01

3. Integrative human and murine multi-omics: Highlighting shared biomarkers in the neuronal ceroid lipofuscinoses;Neurobiology of Disease;2023-12

4. Neuronal progenitor cells-based metabolomics study reveals dysregulated lipid metabolism and identifies putative biomarkers for CLN6 disease;Scientific Reports;2023-10-29

5. Metal mixture and osteoporosis risk: Insights from plasma metabolite profiling;Ecotoxicology and Environmental Safety;2023-09